PeptidePedia The community reference

Liquid chromatography-mass spectrometry (revision 6)

Old revision·23:52, 19 Nov 2024·ForgeryFinder

This is an old revision of this page, as it stood at 23:52, 19 Nov 2024, saved by ForgeryFinder with the summary space between number and unit per PP:MOS. It may differ substantially from the current revision, and any error it contains may since have been corrected.
Liquid chromatography-mass spectrometry
AbbreviationLC-MS
CombinesChromatographic separation and mass detection
InterfaceUsually electrospray
AddsIdentity to a retention-based separation
Analytical method infobox · conventions

Liquid chromatography-mass spectrometry couples a chromatographic separation to a mass spectrometer, so that each eluting peak is characterised by both its retention time and its mass. It converts a weak identification into a strong one.[1]

The interface is almost always electrospray, which works directly from flowing solution. This compatibility is what made the technique routine, and it constrains the chromatography: mobile phases must be volatile and free of non-volatile buffers.[2]

For peptide work its principal use is identity confirmation — establishing that the peak dominating a chromatogram has the expected mass — and characterisation of impurities, since each minor peak carries a mass that often identifies what it is.[3]

What it adds over either alone

[edit]

Chromatography alone establishes that one species dominates; mass spectrometry alone establishes that a species of the expected mass is present. Together they establish that the dominant species has the expected mass, which is a materially stronger statement than either.[1]

Impurity identification is where the combination is most valuable. A deletion sequence appears as a peak of lower mass by one residue; an oxidised species by 16 Da more; an incompletely deprotected species by the mass of the retained group. See Resin cleavage and Solid-phase peptide synthesis.[3]

Tandem operation — selecting a precursor, fragmenting it, and measuring the fragments — adds sequence information and can locate a modification to a residue rather than merely detecting it.[1]

References

  1. ^ a b c Aebersold R, Mann M. "Mass spectrometry-based proteomics." Nature 422(6928):198–207 (2003). PMID 12634793.
  2. ^ Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM. "Electrospray ionization for mass spectrometry of large biomolecules." Science 246(4926):64–71 (1989). PMID 2675315.
  3. ^ a b United States Pharmacopeia, General Chapter <1503>, Quality Attributes of Synthetic Peptide Drug Substances.